TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,784,976 | -1.2% | 761,796 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $11,924,662 | -19.1% | 759,050 | -15.1% | 0.00% | -25.0% |
| Q1 2023 | $14,740,699 | +1.6% | 894,459 | -3.8% | 0.00% | 0.0% |
| Q4 2022 | $14,511,464 | +26.7% | 930,222 | +5.3% | 0.00% | 0.0% |
| Q3 2022 | $11,453,000 | -6.7% | 883,090 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $12,274,000 | +4.6% | 874,199 | +6.6% | 0.00% | +33.3% |
| Q1 2022 | $11,738,000 | -51.5% | 819,733 | -53.9% | 0.00% | -50.0% |
| Q4 2021 | $24,214,000 | -33.6% | 1,776,538 | -20.2% | 0.01% | -25.0% |
| Q3 2021 | $36,447,000 | -4.5% | 2,225,055 | -1.9% | 0.01% | 0.0% |
| Q2 2021 | $38,182,000 | -18.2% | 2,268,657 | -11.3% | 0.01% | -20.0% |
| Q1 2021 | $46,678,000 | +6.3% | 2,556,271 | +6.0% | 0.01% | -9.1% |
| Q4 2020 | $43,911,000 | +55.9% | 2,412,695 | +52.8% | 0.01% | +37.5% |
| Q3 2020 | $28,163,000 | +26.1% | 1,578,708 | +26.8% | 0.01% | +33.3% |
| Q2 2020 | $22,330,000 | +321.6% | 1,245,410 | +256.9% | 0.01% | +200.0% |
| Q1 2020 | $5,296,000 | -0.2% | 348,921 | +29.7% | 0.00% | +100.0% |
| Q4 2019 | $5,309,000 | +10.0% | 269,124 | -4.1% | 0.00% | 0.0% |
| Q3 2019 | $4,828,000 | +50.3% | 280,683 | +54.6% | 0.00% | 0.0% |
| Q2 2019 | $3,213,000 | +96.0% | 181,584 | +125.7% | 0.00% | – |
| Q1 2019 | $1,639,000 | +758.1% | 80,444 | +607.6% | 0.00% | – |
| Q4 2018 | $191,000 | – | 11,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |